Literature DB >> 28275202

Low-Volume Resuscitation for Hemorrhagic Shock: Understanding the Mechanism of PEG-20k.

Valerie Plant1, Dan W Parrish1, Ashley Limkemann1, Paula Ferrada1, Michel Aboutanos1, Martin J Mangino2.   

Abstract

Hemorrhagic shock leads to cell and tissue swelling and no reflow from compressed capillaries. Cell impermeants, including polyethylene glycol-20,000 (PEG-20k), reverse ischemia-induced cell swelling, extend low-volume resuscitation (LVR) time after shock, and increase tolerance to the low-volume state. The purpose of this study was to explore the mechanisms of action of PEG-20k containing LVR solutions. We hypothesized that PEG-20k acts as both an oncotic agent and an impermeant in the microcirculation, which moves water out of the space and into the capillaries to affect peripheral capillary filling and enhanced perfusion during the low-volume state. Rats were hemorrhaged until arterial lactate reached 9-10 mM/liter. Then, saline-based LVR solutions containing various impermeant materials were administered (10% blood volume). The LVR times for these solutions were determined by measuring the amount of time required for plasma lactate to climb back to 9 to 10 mM after LVR administration (low-volume tolerance). Capillary blood flow was measured by colored microspheres, and blood volume was measured by fluorescein isothiocyanate-labeled albumin dilution. Gluconate (impermeant), albumin (colloid), and PEG-20k (hybrid) increased LVR time over saline by 4-, 3-, and 8-fold, respectively. The combination of impermeant + albumin produced a biologic effect that was similar to PEG-20k alone. Capillary blood flow and plasma volume were decreased after shock with saline LVR but increased with PEG-20k, relative to saline. These data are consistent with the hypothesis that PEG-20k may act by establishing multiple osmotic gradients in the microcirculation to drive cell-to-capillary water transfer during hypovolemic shock.
Copyright © 2017 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28275202     DOI: 10.1124/jpet.116.239822

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  Overcoming anti-PEG antibody mediated accelerated blood clearance of PEGylated liposomes by pre-infusion with high molecular weight free PEG.

Authors:  Morgan D McSweeney; Lauren S L Price; Timothy Wessler; Elizabeth C Ciociola; Leah B Herity; Joseph A Piscitelli; Alexander C DeWalle; Taylor N Harris; Andy K P Chan; Ran Sing Saw; Peiqi Hu; J Charles Jennette; M Gregory Forest; Yanguang Cao; Stephanie A Montgomery; William C Zamboni; Samuel K Lai
Journal:  J Control Release       Date:  2019-08-24       Impact factor: 9.776

2.  Combined Therapy With Polyethylene Glycol-20k and MCC950 Preserves Post-Resuscitated Myocardial Function in a Rat Model of Cardiac Arrest and Cardiopulmonary Resuscitation.

Authors:  Lian Liang; Guozhen Zhang; Hui Li; Cheng Cheng; Tao Jin; Chenglei Su; Yan Xiao; Jennifer Bradley; Mary A Peberdy; Joseph P Ornato; Martin J Mangino; Wanchun Tang
Journal:  J Am Heart Assoc       Date:  2021-04-22       Impact factor: 5.501

3.  Thromboelastographic analysis of novel polyethylene glycol based low volume resuscitation solutions.

Authors:  Loren K Liebrecht; Jason Newton; Erika J Martin; Nina Wickramaratne; Sudha Jayaraman; Jinfeng Han; Michel Aboutanos; Donald F Brophy; Martin J Mangino
Journal:  PLoS One       Date:  2018-11-15       Impact factor: 3.240

4.  Effects of a novel low volume resuscitation solutions on coagulation and platelet function.

Authors:  Loren K Liebrecht; Jason Newton; Erika J Martin; Niluka Wickramaratne; Sudha Jayaraman; Jinfeng Han; Michel Aboutanos; Donald F Brophy; Martin J Mangino
Journal:  PLoS One       Date:  2019-05-01       Impact factor: 3.240

5.  Poloxamer 188 Protects Isolated Adult Mouse Cardiomyocytes from Reoxygenation Injury.

Authors:  Michele M Salzman; Jason A Bartos; Demetris Yannopoulos; Matthias L Riess
Journal:  Pharmacol Res Perspect       Date:  2020-12

6.  Assessment of machine perfusion conditions for the donation after circulatory death heart preservation.

Authors:  Renee Cholyway; Oluwatoyin Akande; Adolfo Gabriele Mauro; Eleonora Mezzaroma; Rui Wang; Kristine Kenning; Stefano Toldo; Mohammed Quader
Journal:  Artif Organs       Date:  2022-02-22       Impact factor: 2.663

7.  Physician Awareness of Immune Responses to Polyethylene Glycol-Drug Conjugates.

Authors:  Morgan D McSweeney; Zina C Versfeld; Delesha M Carpenter; Samuel K Lai
Journal:  Clin Transl Sci       Date:  2018-01-31       Impact factor: 4.689

8.  Effects of Polyethylene Glycol-20k on Coronary Perfusion Pressure and Postresuscitation Myocardial and Cerebral Function in a Rat Model of Cardiac Arrest.

Authors:  Weiwei Ge; Guanghui Zheng; Xianfei Ji; Fenglian He; Juntao Hu; Jennifer L Bradley; Christine E Moore; Mary A Peberdy; Joseph P Ornato; Martin J Mangino; Wanchun Tang
Journal:  J Am Heart Assoc       Date:  2020-01-30       Impact factor: 5.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.